144 related articles for article (PubMed ID: 24389618)
1. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
Takayama K
Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
[TBL] [Abstract][Full Text] [Related]
2. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
[TBL] [Abstract][Full Text] [Related]
3. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
[TBL] [Abstract][Full Text] [Related]
4. Oligoarginine-based prodrugs with self-cleavable spacers for caco-2 cell permeation.
Takayama K; Suehisa Y; Fujita T; Nguyen JT; Futaki S; Yamamoto A; Kiso Y; Hayashi Y
Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1515-20. PubMed ID: 18981599
[TBL] [Abstract][Full Text] [Related]
5. A novel approach using functional peptides for efficient intestinal absorption of insulin.
Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
7. Development of oligoarginine-drug conjugates linked to new peptidic self-cleavable spacers toward effective intestinal absorption.
Hayashi Y; Takayama K; Suehisa Y; Fujita T; Nguyen JT; Futaki S; Yamamoto A; Kiso Y
Bioorg Med Chem Lett; 2007 Sep; 17(18):5129-32. PubMed ID: 17662604
[TBL] [Abstract][Full Text] [Related]
8. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
9. Potential of single cationic amino acid molecule "Arginine" for stimulating oral absorption of insulin.
Kamei N; Khafagy ES; Hirose J; Takeda-Morishita M
Int J Pharm; 2017 Apr; 521(1-2):176-183. PubMed ID: 28223245
[TBL] [Abstract][Full Text] [Related]
10. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
11. Oligoarginine-PEG-lipid particles for gene delivery.
Maitani Y; Hattori Y
Expert Opin Drug Deliv; 2009 Oct; 6(10):1065-77. PubMed ID: 19637981
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
Kamei N; Morishita M; Eda Y; Ida N; Nishio R; Takayama K
J Control Release; 2008 Nov; 132(1):21-5. PubMed ID: 18727945
[TBL] [Abstract][Full Text] [Related]
13. Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells.
Hirose H; Takeuchi T; Osakada H; Pujals S; Katayama S; Nakase I; Kobayashi S; Haraguchi T; Futaki S
Mol Ther; 2012 May; 20(5):984-93. PubMed ID: 22334015
[TBL] [Abstract][Full Text] [Related]
14. Current Understanding of Direct Translocation of Arginine-Rich Cell-Penetrating Peptides and Its Internalization Mechanisms.
Takeuchi T; Futaki S
Chem Pharm Bull (Tokyo); 2016; 64(10):1431-1437. PubMed ID: 27725497
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides.
Kawaguchi Y; Takeuchi T; Kuwata K; Chiba J; Hatanaka Y; Nakase I; Futaki S
Bioconjug Chem; 2016 Apr; 27(4):1119-30. PubMed ID: 27019270
[TBL] [Abstract][Full Text] [Related]
16. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
17. Novel system to achieve one-pot modification of cargo molecules with oligoarginine vectors for intracellular delivery.
Takayama K; Tadokoro A; Pujals S; Nakase I; Giralt E; Futaki S
Bioconjug Chem; 2009 Feb; 20(2):249-57. PubMed ID: 19161253
[TBL] [Abstract][Full Text] [Related]
18. Lipo-oligoarginine-based intracellular delivery.
Lee JS; Tung CH
Methods Mol Biol; 2013; 991():281-92. PubMed ID: 23546678
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of oligoarginine-oligonucleotide conjugates and oligoarginine-bridged oligonucleotide pairs.
Wei Z; Tung CH; Zhu T; Stein S
Bioconjug Chem; 1994; 5(5):468-74. PubMed ID: 7849079
[TBL] [Abstract][Full Text] [Related]
20. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
